Tuesday, March 26, 2013
BioCryst Starts Clinical Trial
Durham's BioCryst Pharmaceuticals announced Monday that it has started a Phase 1 multi-million-dollar clinical trial to test the safety of its drug that treats hereditary angioedema.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment